Aptalis markets a broad line of pharmaceutical products and services used in the treatment of cystic fibrosis and gastrointestinal disorders. In North America and in several markets within Europe, Aptalis's products are marketed by its own specialized sales forces.
Aptalis has also established a global network of partners to market its products in more than 40 countries. Depending on the particular country and the registration requirements of that country, all or a portion of Aptalis's products are available for sale.
|Aptalis Worldwide||North America||Latin America||Europe||Asia||Africa||Middle East||Oceania|